Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Buy
51
UHS Quote, Financials, Valuation and Earnings
Last price:
$180.93
Seasonality move
:
8.06%
Day range:
$179.64 - $181.22
52-week range:
$150.11 - $243.25
Dividend yield:
0.44%
P/E ratio:
12.07x
P/S ratio:
0.80x
P/B ratio:
1.81x
Volume:
127K
Avg. volume:
703.2K
1-year change:
18.38%
Market cap:
$12B
Revenue:
$14.3B
EPS (TTM):
$15.02
Analysts' Opinion
-
Consensus RatingUniversal Health Services has received a consensus rating of Hold. The company's average rating is a Hold based on 7 Buy ratings, 10 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $238.21, Universal Health Services has an estimated upside of 31.45% from its current price of $181.22.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $197.00 representing -8.71% downside risk from its current price of $181.22.
Fair Value
-
According to the consensus of 17 analysts, Universal Health Services has 31.45% upside to fair value with a price target of $238.21 per share.
UHS vs. S&P 500
-
Over the past 5 trading days, Universal Health Services has underperformed the S&P 500 by -3.6% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Universal Health Services does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Universal Health Services has grown year-over-year revenues for 17 quarters straight. In the most recent quarter Universal Health Services reported revenues of $4B.
Earnings Growth
-
Universal Health Services has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Universal Health Services reported earnings per share of $3.80.
Enterprise value:
16.6B
EV / Invested capital:
1.46x
Price / LTM sales:
0.80x
EV / EBIT:
10.79x
EV / Revenue:
1.08x
PEG ratio (5yr expected):
0.21x
EV / Free cash flow:
17.33x
Price / Operating cash flow:
12.93x
Enterprise value / EBITDA:
7.82x
Gross Profit (TTM):
$13.8B
Return On Assets:
7.3%
Net Income Margin (TTM):
6.66%
Return On Equity:
16.1%
Return On Invested Capital:
9.2%
Operating Margin:
9.69%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $13.2B | $14B | $15.4B | $3.6B | $4B | |
| Gross Profit | $11.8B | $12.5B | $13.8B | $3.2B | $3.6B | |
| Operating Income | $1.1B | $1.1B | $1.5B | $285.4M | $384.2M | |
| EBITDA | $1.6B | $1.6B | $2.1B | $409.9M | $534.9M | |
| Diluted EPS | $9.72 | $9.53 | $15.02 | $2.40 | $3.80 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3B | $2.3B | $2.5B | $2.8B | $2.8B | |
| Total Assets | $13B | $12.8B | $13.4B | $13.9B | $14.4B | |
| Current Liabilities | $2.6B | $2B | $1.9B | $2B | $2B | |
| Total Liabilities | $6.9B | $6.5B | $7.5B | $7.8B | $7.7B | |
| Total Equity | $6B | $6.4B | $5.9B | $6.1B | $6.7B | |
| Total Debt | $3.6B | $3.8B | $4.7B | $4.9B | $4.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1B | $1.1B | $1.9B | $161.7M | $333M | |
| Cash From Investing | -$653.7M | -$772.8M | -$942M | -$176.4M | -$265.6M | |
| Cash From Financing | -$436M | -$327M | -$900.4M | $18M | -$89.7M | |
| Free Cash Flow | $261.6M | $411.6M | $956.8M | -$38.3M | $85M | |
UHS
Sector
Market Cap
$12B
$45.6M
Price % of 52-Week High
74.5%
45.55%
Dividend Yield
0.44%
0%
Shareholder Yield
4.15%
-0.74%
1-Year Price Total Return
18.38%
-31.35%
Beta (5-Year)
1.278
0.772
Dividend yield:
0.44%
Annualized payout:
$0.80
Payout ratio:
5.25%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$181.19
200-day SMA
Sell
Level
$197.53
Bollinger Bands (100)
Sell
Level
197.31 - 232.41
Chaikin Money Flow
Buy
Level
133.7M
20-day SMA
Sell
Level
$190.73
Relative Strength Index (RSI14)
Sell
Level
32.91
ADX Line
Buy
Level
10.06
Williams %R
Neutral
Level
-75.3568
50-day SMA
Sell
Level
$202.72
MACD (12, 26)
Sell
Level
-6.80
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
111.5M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.8338)
Buy
CA Score
(Annual)
Level (0.0408)
Buy
Beneish M-Score
(Annual)
Level (-2.57)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.6)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two key segments: Acute Care Hospital Services and Behavioral Health Services. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.
Stock Forecast FAQ
In the current month, UHS has received 7 Buy ratings 10 Hold ratings, and 0 Sell ratings. The UHS average analyst price target in the past 3 months is $238.21.
-
Where Will Universal Health Services Stock Be In 1 Year?
According to analysts, the consensus estimate is that Universal Health Services share price will rise to $238.21 per share over the next 12 months.
-
What Do Analysts Say About Universal Health Services?
Analysts are divided on their view about Universal Health Services share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Universal Health Services is a Sell and believe this share price will drop from its current level to $197.00.
-
What Is Universal Health Services's Price Target?
The price target for Universal Health Services over the next 1-year time period is forecast to be $238.21 according to 17 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 10 analysts rate the stock a Hold.
-
Is UHS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Universal Health Services is a Hold. 10 of 17 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of UHS?
You can purchase shares of Universal Health Services via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Universal Health Services shares.
-
What Is The Universal Health Services Share Price Today?
Universal Health Services was last trading at $180.93 per share. This represents the most recent stock quote for Universal Health Services. Yesterday, Universal Health Services closed at $181.22 per share.
-
How To Buy Universal Health Services Stock Online?
In order to purchase Universal Health Services stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
